0001104659-20-083754.txt : 20200715 0001104659-20-083754.hdr.sgml : 20200715 20200715163907 ACCESSION NUMBER: 0001104659-20-083754 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200713 FILED AS OF DATE: 20200715 DATE AS OF CHANGE: 20200715 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Hudson Frederick M. CENTRAL INDEX KEY: 0001438462 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35518 FILM NUMBER: 201029457 MAIL ADDRESS: STREET 1: 9715 KEY WEST AVENUE CITY: ROCKVILLE STATE: MD ZIP: 20850 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SUPERNUS PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0001356576 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 9715 KEY WEST AVENUE CITY: ROCKVILLE STATE: MD ZIP: 20850 BUSINESS PHONE: 301-838-2500 MAIL ADDRESS: STREET 1: 9715 KEY WEST AVENUE CITY: ROCKVILLE STATE: MD ZIP: 20850 FORMER COMPANY: FORMER CONFORMED NAME: SUPERNUS PHARMACEUTICALS INC DATE OF NAME CHANGE: 20060317 4 1 a4.xml 4 X0306 4 2020-07-13 0 0001356576 SUPERNUS PHARMACEUTICALS, INC. SUPN 0001438462 Hudson Frederick M. C/O SUPERNUS PHARMACEUTICALS, INC. 9715 KEY WEST AVENUE ROCKVILLE MD 20850 1 0 0 0 Common Stock 2020-07-13 4 M 0 8750 2.56 A 18961 D Common Stock 2020-07-13 4 S 0 920 24.44 D 18041 D Director Stock Option (Right to Buy) 2.56 2020-07-13 4 M 0 8750 0 D 2011-11-16 2020-11-16 Common Stock 8750 0 D Transaction made pursuant to a 10b5-1 trading plan adopted June 12, 2020. Includes 5,211 restricted stock units previously reported that will be settled in common stock upon vesting, such vesting to occur on February 21, 2021. /s/ Gregory S. Patrick, as attorney-in-fact 2020-07-15